tenk.fyi

CG Oncology, Inc.

CGONNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$4.0M

254.7% YoY

Net Income

-$161.0M

82.9% YoY

EPS

$-2.08

47.5% YoY

Cash

$32.5M

87.4% YoY

FY 2025 · As of 2025-12-31